According to Accolade's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.87299. At the end of 2023 the company had a P/S ratio of 1.78.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.78 | -0.52% |
2022 | 1.79 | -71.33% |
2021 | 6.23 | -66.14% |
2020 | 18.4 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Sotera Health
SHC | 3.04 | 62.33% | ๐บ๐ธ USA |